FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/11/010570 [Registered on: 21/11/2017] Trial Registered Prospectively
Last Modified On: 20/11/2017
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To evaluate the efficacy of cutis capsule and cutis oil in Atopic Eczema 
Scientific Title of Study   A randomized open labelled , parallel group study to evaluate the safety and efficacy of cutis capsule and cutis oil in Atopic Eczema 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrRajesh Sood 
Designation  Reader 
Affiliation  Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, Paprola  
Address  P.G. Deptt. of Samhita avum Siddhant, Skin Care Unit OPD Number 715 Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital, Paprola District Kangra (HP)     

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418102424  
Fax  01894-242064  
Email  drrajeshsood@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrRajesh Sood 
Designation  Reader 
Affiliation  Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, Paprola  
Address  P.G. Deptt. of Samhita avum Siddhant, Skin Care Unit OPD Number 715 Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital, Paprola District Kangra (HP)     

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418102424  
Fax  01894-242064  
Email  drrajeshsood@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrRajesh Sood 
Designation  Reader 
Affiliation  Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, Paprola  
Address  P.G. Deptt. of Samhita avum Siddhant, Skin Care Unit OPD Number 715 Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital, Paprola District Kangra (HP)     

Kangra
HIMACHAL PRADESH
176115
India 
Phone  9418102424  
Fax  01894-242064  
Email  drrajeshsood@gmail.com  
 
Source of Monetary or Material Support  
vasu Research Centre 896/A. GIDC Makarpura, Vododra 390010   
 
Primary Sponsor  
Name  Vasu Research Centre 
Address  A Division of Vasu Healthcare Pvt. Ltd. 896/A, GIDC, Makarpura, Vadodra - 390010       
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrRajesh Sood  Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital  Skin Care Unit OPD Number 715
Kangra
HIMACHAL PRADESH 
09418102424

drrajeshsood@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Rajiv Gandhi Govt. Post Graduate Ayurvedic College and Hospital, Paprola   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Suffering from atopic eczema with EASI score 15,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Cutis capsule  Cutis capsule- ingredients- Mahamanjisthadi kwath,Panchnimba churn,Triphala churn,Acacia catechu,Tinospora cordifolia,Curcuma longa,Ganthak rasayan Mode of administration-oral Dose - 1 capsule thrice a day with water after meal  
Intervention  Cutis oil  Cutis oil- Ingredients- Azadirachta indica oil,Pongamia pinnata oil,Brassica campestris,Psoralea corylifolia,Hydnocarpus laurifolia,Sesamum indicum,Mahatuvrak tail,Olea europoea Mode of administration- external application over lesion Dose- 3 times a day.   
Comparator Agent  Cutis Oil and Cutis capsule combination   Dose : External application of oil three times a day, 1 capsule thrice a day with water.   
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Non pregnant,non lactating females
2. Patient with atopic eczema according to Rajka and Hanifin criteria
3. Patient with EASI score 15 at time of screening

 
 
ExclusionCriteria 
Details  1. Pregnant,lactating mother
2. Patient with infected atopic eczema
3. Patient with severe systemic disorder
4. Patient with known hypersensitivity to excipients of drugs 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in the eczematic area and skin moisture level at end of study  
 
0 day and 56th Day of the study
 
 
Secondary Outcome  
Outcome  TimePoints 
EASI score, SCORAD score,DLQI score at starting and at end of study  at 14 days,28 days,after 56 days
 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   27/11/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="7" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

The clinical study entitled “A randomized open labelled, Parallel group study to evaluate the safety and efficacy of Cutis Oil and Cutis capsule in Atopic Eczema” is carried out in the skin care unit of R.G.G.P.G. Ayu.  College & Hospital, Paprola, Distt. Kangra (H.P.). This trial is sponsored by Vasu Research Centre, Vadodara. Two drugs - Cutis oil and Cutis capsule will be clinically tested in the patients of atopic eczema  with EASI score 15.
Total three group are made and 30 patients will  be recruited in each group.


Group A - Cutis capsule group                      [Dose -1 capsule thrice a day after meal] 
Group B - Cutis oil group                               [Dose - topical application thrice a day on affected area] 
Group C - Cutis capsule and Cutis oil group [Dose - Topcial Application of oil and 1 tablet thrice a day]

 
Close